Hemispherx Biopharma Repurposes Ampligen in Immuno-Oncology
31 mai 2017 12h03 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 31, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) ("Hemispherx" or the “Company") announced today that it continues to bolster its scientific capabilities by...
Hemispherx Biopharma Bolsters Manufacturing and Scientific Capabilities Through Key Consulting and Management Appointments
19 juil. 2016 08h35 HE
|
Hemispherx Biopharma, Inc.
Promotes Carol Smith, Ph.D., to Manager of Quality as Part of Manufacturing Optimization Retains Step Change Pharma as Advisor to Strengthen Manufacturing and Technical Infrastructure Retains...